Assembly Biosciences, a biotechnology company based in South San Francisco, develops treatments for chronic hepatitis B and other infectious diseases, with a pipeline including multiple antiviral agents. The company, which went public in December 2010, employs 65 people.
ASMB has been in the news recently: There is no relevant information regarding Assembly Biosciences in the provided article content. The article focuses on political issues in California and New York, as well as initiatives by Adobe and General Assembly to enhance AI skills in the UK and India.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
